# Reapplix A/S

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/reapplix-a-s

- Industry: Healthcare
- Headquarters: Denmark
- Website: www.reapplix.com
- Total disclosed funding: $8.8M
- Latest round: Seed (Dec 1, 2012)
- Investors on record: 4

## About

Reapplix Inc. specializes in innovative wound healing solutions, particularly addressing diabetic foot ulcers with its 3C Patch® System, which utilizes patient-derived blood components to facilitate healing.Reapplix Inc., founded in 2008 in Denmark, develops advanced treatments for chronic wounds. The company has not undergone any significant strategic pivots and operates independently. Rasmus Lundquist is the founder, while Kira Rupprecht serves as the CEO. Reapplix has raised a total of DKK 150.000 mn across multiple funding rounds, with the most recent round in November 2021, attracting investors such as Lauxera Capital Partners, MK Ventures, North-East Venture, Novo Holdings, and Vaekstfonden.Reapplix focuses on innovative wound healing solutions, particularly for diabetic foot ulcers. Its flagship 3C Patch® System utilizes a small sample of the patient's blood to create a patch rich in proteins and growth factors that is applied at the wound site. The product aims to accelerate healing, addressing the issue that roughly 60% of diabetic foot ulcers do not heal with traditional treatments. Reapplix's technology is clinically validated and is recommended by the International Working Group on the Diabetic Foot (IWGDF). The company's products are marketed to healthcare professionals across international markets, including Europe and the United States.Reapplix plans to expand its product offerings and is currently working on upcoming innovations within the wound care sector. The company aims to enter new geographic markets, specifically targeting expansion into additional regions in Europe and the United States by 2023. The funding raised in November 2021 will be utilized to support these initiatives, enhancing product development and market penetration.

## Funding rounds

- Seed, Dec 1, 2012, $7.1M — SEED Capital, Vaekstfonden, Novo Holdings
- Seed, Sep 2, 2010, $1.3M — SEED Capital
- Seed, Mar 9, 2009, $0.3M — Accelerace

## Investors

- Accelerace (https://capitalatlas.ai/funds/accelerace) — Seed
- SEED Capital (https://capitalatlas.ai/funds/seed-capital) — Seed
- Vaekstfonden (https://capitalatlas.ai/funds/vaekstfonden) — Seed
- Novo Holdings — Seed